
Opthea’s Exciting Phase 2b Study Results on Wet AMD: A Game-Changer in Eye Health!
Exciting New Development in Wet Age-Related Macular Degeneration Research: Opthea’s Sozinibercept Phase 2b Data In the world of ophthalmology, the publication of new research findings is always an exciting event. Recently, Opthea Limited, a clinical-stage biopharmaceutical company, announced the release of sozinibercept Phase 2b data in the prestigious peer-reviewed journal, Ophthalmic Surgery, Lasers and Imaging…